CARPHA Receives Automated Instruments to Assist in Gene Surveillance

Port of Spain, Trinidad and Tobago. 20 July 2023. The Caribbean Public Health Agency (CARPHA) has received laboratory equipment to support genomic surveillance at its Medical Microbiology Laboratory for its Member States.

The equipment was procured through the New Variant Assessment Platform, led by United Kingdom Health Security Agency (UKHSA). This marks another milestone in CARPHA’s mission to strengthen its systems to better detect and respond to emerging diseases in the Caribbean region.

The items received are two liquid handling instruments namely, the Mosquito® HV, and the Dragonfly Discovery.

Dr. Joy St. John, Executive Director of CARPHA. “Our overall collaboration with UKHSA has been very supportive to our work with our Member States. These devices have ensured further strengthening of CARPHA’s gene sequencing capabilities, maintaining the cutting-edge array of laboratory services we provide to our Member States.”

“The acquisition of the instruments will serve to advance our laboratory productivity, shorten turnaround times, and reduce costs per sample. Overall, the instruments will improve sample processing accuracy,” stated Dr. Michelle Hamilton, Head, Laboratory Services and Networks. The Mosquito® HV is a highly accurate and precise multichannel pipetting system. The

Dragonfly Discovery enables innovative, low volume liquid dispensing that is compatible with a wide range of applications including molecular biology and genomics, and biochemical assays.

“Both devices will be used together to increase sequencing capacity by automating some of the preparation steps. These instruments will allow CARPHA to carry out multiple sample runs, and switch between applications with minimal setup required,” explained Ms. SueMin Nathaniel, Manager of Laboratory Services at CARPHA.

The acquisition also included a supply of consumables. Laboratory staff at the CMML will receive training in the use of the instruments.

During the first half of 2023, CARPHA signed a Memorandum of Understanding with the UKHSA. The agreement builds on a longterm collaboration to improve regional health security across the Caribbean. The MoU includes commitments to define strategies for combatting infectious disease threats, non- communicable diseases, strengthening outbreak response, building laboratory and workforce capacity, and improving healthy safer tourism. There is specific emphasis on genomic surveillance of high priority pathogens which emerged as a new service during the COVID-19 pandemic.

Opioid Settlement Fund. This crucial funding will enable the integration of an Opioid Treatment Program and create a Comprehensive Integrative Program, eliminating stigma and offering vital Medication Assisted Treatment to patients with Opioid Use Disorder. Considering the devastating impact of the opioid epidemic in the Bronx, directing these resources towards the hardest-hit communities will be a significant step in providing essential care and support to those in need. Jacobi’s dedication to expanding their treatment options demonstrates their commitment to patient-centered care, and I am honored to stand behind their efforts to combat this crisis,” said State Senator Nathalia Fernandez, Chair of the Committee of Alcoholism & Substance Use Disorders.

“Addiction is not a partisan issue,” said Assemblymember John Zaccaro, Jr. “The Bronx is the epicenter of the opioid crisis in New York State and far too many of our family members, friends, and neighbors continue to struggle without the necessary resources. Today’s incredible announcement that NYC Health & Hospitals / Jacobi Medical Center received more than half a million dollars to expand their

Comprehensive Addiction Treatment Center means that we can provide more essential services to help our community free ourselves from the tight grasp of addiction.” If you are interested in making an appointment with our outstanding Substance Use Disorder Treatment team, please call us at (718) 9184465.